August 19, 2025 · Form 4 insider transaction
Schwartz Jonathan David sold 805 shares of Rocket Pharmaceuticals Inc at $3.00 per share, a transaction worth $2.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.; The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.